Pancreatic adenocarcinoma upregulated factor (PAUF) confers resistance to pancreatic cancer cells against oncolytic parvovirus H-1 infection through IFNA receptor-mediated signaling.

Biochemical and Biophysical Research Communications
Sirichat KaowinnYoung-Hwa Chung

Abstract

Pancreatic adenocarcinoma upregulated factor (PAUF), a novel oncogene, plays a crucial role in the development of pancreatic cancer, including its metastasis and proliferation. Therefore, PAUF-expressing pancreatic cancer cells could be important targets for oncolytic virus-mediated treatment. Panc-1 cells expressing PAUF (Panc-PAUF) showed relative resistance to parvovirus H-1 infection compared with Panc-1 cells expressing an empty vector (Panc-Vec). Of interest, expression of type I IFN-α receptor (IFNAR) was higher in Panc-PAUF cells than in Panc-Vec cells. Increased expression of IFNAR in turn increased the activation of Stat1 and Tyk2 in Panc-PAUF cells compared with that in Panc-Vec cells. Suppression of Tyk2 and Stat1, which are important downstream molecules for IFN-α signaling, sensitized pancreatic cancer cells to parvovirus H-1-mediated apoptosis. Further, constitutive suppression of PAUF sensitized Bxpc3 pancreatic cancer cells to parvovirus H-1 infection. Taken together, these results suggested that PAUF conferred resistance to pancreatic cancer cells against oncolytic parvovirus H-1 infection through IFNAR-mediated signaling.

References

Oct 6, 1998·Annual Review of Biochemistry·G R StarkR D Schreiber
Oct 20, 1999·Cellular and Molecular Life Sciences : CMLS·T C Yeh, S Pellegrini
Jan 30, 2003·The EMBO Journal·Josiane RagimbeauSandra Pellegrini
Feb 3, 2004·Proceedings of the National Academy of Sciences of the United States of America·Nikolai N KhodarevRalph R Weichselbaum
Oct 31, 2006·International Journal of Cancer. Journal International Du Cancer·Mårten FryknäsAnders Isaksson
Oct 9, 2007·Biochemical and Biophysical Research Communications·Hisamitsu IdeShigeo Horie
Nov 24, 2007·Drugs·Paula GhanehJohn P Neoptolemos
Nov 13, 2008·Proceedings of the National Academy of Sciences of the United States of America·Ralph R WeichselbaumAndy J Minn
Oct 27, 2009·International Journal of Cancer. Journal International Du Cancer·Sebastian DempeChristiane Dinsart
Dec 24, 2009·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Béatrice Payelle-Brogard, Sandra Pellegrini
Feb 19, 2011·Future Virology·Aaron Yun Chen, Jianming Qiu
Jul 1, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Irina KiprianovaJörg R Schlehofer
Nov 30, 2012·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Sujata HalderMavis Agbandje-McKenna

❮ Previous
Next ❯

Citations

Feb 9, 2016·Expert Opinion on Biological Therapy·Cherif Akladios, Marc Aprahamian
Dec 19, 2020·Open Medicine·Haotian LuYing Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.